pharmaceutical preparations for the treatment of central nervous system diseases and disorders, neurological disorders, mental illness, depression, psychosis, menopausal complaints, hormone deficiencies, and sleep disorders; pharmaceutical preparations, namely, gynecological preparations

Cosmetic preparations containing hemp-derived CBD with a THC concentration of not more than 0.3 percent; Cosmetic preparations for skin care containing hemp-derived CBD with a THC concentration of not more than 0.3 percent; Non-medicated skin care preparations containing hemp-derived CBD with a THC concentration of not more than 0.3 percent

Dietary supplements